$MNKD
MANNKIND CORP

2014 Q4 Form 10-Q Financial Statement

#000119312514406347 Filed on November 10, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $12.50M $19.10M $17.50M
YoY Change -28.98% 9.14% 90.22%
% of Gross Profit
Research & Development $17.60M $19.18M $27.28M
YoY Change -39.31% -29.7% 7.18%
% of Gross Profit
Depreciation & Amortization $3.010M $2.449M $2.874M
YoY Change -23.8% -14.79% -11.21%
% of Gross Profit
Operating Expenses $30.10M $38.27M $44.76M
YoY Change -35.41% -14.51% 26.01%
Operating Profit -$38.27M -$44.76M
YoY Change -14.51% 26.14%
Interest Expense -$6.400M -$6.200M -$6.100M
YoY Change 1.59% 1.64% 19.61%
% of Operating Profit
Other Income/Expense, Net $0.00 $7.898M $10.00K
YoY Change -100.0% 78880.0% -100.38%
Pretax Income -$36.40M -$36.52M -$50.82M
YoY Change -32.09% -28.14% 17.52%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$36.44M -$36.52M -$50.82M
YoY Change -31.99% -28.14% 18.64%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$458.4K -$463.2K -$856.7K
COMMON SHARES
Basic Shares Outstanding 405.7M shares 402.4M shares 301.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.8M $172.5M $93.80M
YoY Change 70.62% 83.9% 4366.67%
Cash & Equivalents $120.8M $172.5M $93.80M
Short-Term Investments
Other Short-Term Assets $20.20M $20.30M $5.200M
YoY Change 267.27% 290.38% -75.36%
Inventory $9.670M
Prepaid Expenses $15.00M $15.00M
Receivables $50.44M
Other Receivables $0.00
Total Short-Term Assets $201.2M $193.5M $99.33M
YoY Change 163.72% 94.83% 328.14%
LONG-TERM ASSETS
Property, Plant & Equipment $192.1M $190.9M $177.8M
YoY Change 8.82% 7.36% -4.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $848.0K $2.114M $10.23M
YoY Change -84.63% -79.33% 1945.4%
Total Long-Term Assets $193.3M $193.3M $188.3M
YoY Change 5.99% 2.67% 0.63%
TOTAL ASSETS
Total Short-Term Assets $201.2M $193.5M $99.33M
Total Long-Term Assets $193.3M $193.3M $188.3M
Total Assets $394.4M $386.8M $287.6M
YoY Change 52.5% 34.49% 36.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.394M $17.39M $7.786M
YoY Change 91.55% 123.34% 143.31%
Accrued Expenses $26.21M $27.27M $21.55M
YoY Change 21.13% 26.52% -54.24%
Deferred Revenue
YoY Change
Short-Term Debt $73.00M $0.00 $72.90M
YoY Change -28.64% -100.0%
Long-Term Debt Due $99.40M $99.10M $114.9M
YoY Change -13.75%
Total Short-Term Liabilities $403.4M $293.8M $217.2M
YoY Change 215.63% 35.28% 319.25%
LONG-TERM LIABILITIES
Long-Term Debt $52.60M $122.1M $217.9M
YoY Change -64.46% -43.97% -49.89%
Other Long-Term Liabilities $12.30M $11.57M $20.31M
YoY Change -9.58% -43.01%
Total Long-Term Liabilities $12.30M $11.57M $20.31M
YoY Change -9.58% -43.01% -95.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $403.4M $293.8M $217.2M
Total Long-Term Liabilities $12.30M $11.57M $20.31M
Total Liabilities $468.2M $427.5M $455.3M
YoY Change 61.81% -6.11% -6.43%
SHAREHOLDERS EQUITY
Retained Earnings -$2.495B
YoY Change 8.64%
Common Stock $2.421B $2.418B $2.075B
YoY Change 6.86% 16.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$73.77M -$40.68M -$167.7M
YoY Change
Total Liabilities & Shareholders Equity $394.4M $386.8M $287.6M
YoY Change 52.5% 34.49% 36.76%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$36.44M -$36.52M -$50.82M
YoY Change -31.99% -28.14% 18.64%
Depreciation, Depletion And Amortization $3.010M $2.449M $2.874M
YoY Change -23.8% -14.79% -11.21%
Cash From Operating Activities -$35.74M $100.2M -$32.91M
YoY Change 4.96% -404.59% -3.94%
INVESTING ACTIVITIES
Capital Expenditures -$4.970M -$9.460M -$230.0K
YoY Change -19.45% 4013.04% 91.67%
Acquisitions
YoY Change
Other Investing Activities -$9.250M $9.250M $0.00
YoY Change
Cash From Investing Activities -$14.22M -$210.0K -$230.0K
YoY Change 130.47% -8.7% 91.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.670M 31.23M 98.42M
YoY Change -109.71% -68.27% 2082.26%
NET CHANGE
Cash From Operating Activities -35.74M 100.2M -32.91M
Cash From Investing Activities -14.22M -210.0K -230.0K
Cash From Financing Activities -1.670M 31.23M 98.42M
Net Change In Cash -51.63M 131.3M 65.28M
YoY Change 124.28% 101.07% -318.55%
FREE CASH FLOW
Cash From Operating Activities -$35.74M $100.2M -$32.91M
Capital Expenditures -$4.970M -$9.460M -$230.0K
Free Cash Flow -$30.77M $109.7M -$32.68M
YoY Change 10.37% -435.68% -4.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
120100000
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
405699862 shares
CY2013Q3 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93803000
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
405469034 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
405469034 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2014Q3 us-gaap Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
9000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q3 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
118150000
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
293778000
CY2014Q3 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
0
CY2014Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
72625000
CY2014Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
49521000
CY2014Q3 us-gaap Interest Payable Current
InterestPayableCurrent
958000
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
4055000
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11000
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
17389000
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2413621000
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27269000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
-40678000
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11572000
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12274000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
386818000
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
150000000
CY2014Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
99120000
CY2014Q3 us-gaap Liabilities
Liabilities
427496000
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10287000
CY2014Q3 us-gaap Construction Payable Current
ConstructionPayableCurrent
2739000
CY2014Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
30100000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
172465000
CY2014Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
169700000
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
190923000
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20253000
CY2014Q3 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
2458343000
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
309073000
CY2014Q3 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
260000
CY2014Q3 us-gaap Assets
Assets
386818000
CY2014Q3 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
803000
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2114000
CY2014Q3 us-gaap Assets Current
AssetsCurrent
193521000
CY2014Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15000000
CY2014Q3 mnkd Loan Commitment Asset Noncurrent Portion
LoanCommitmentAssetNoncurrentPortion
1753000
CY2014Q3 mnkd Loan Commitment Asset
LoanCommitmentAsset
5157000
CY2014Q3 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2014Q3 mnkd Potential Proceeds From Warrant Exercises
PotentialProceedsFromWarrantExercises
20000000
CY2014Q3 mnkd Preferred Stock Shares Undesignated
PreferredStockSharesUndesignated
10000000 shares
CY2014Q3 mnkd Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
0
CY2014Q3 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
1011000
CY2014Q3 mnkd Estimated Amounts Credit Exchange Receivable Current
EstimatedAmountsCreditExchangeReceivableCurrent
803000
CY2014Q3 mnkd Estimated Amounts Credit Exchange Receivable Noncurrent
EstimatedAmountsCreditExchangeReceivableNoncurrent
260000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61840000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
369391972 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
369391972 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
111060000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
127794000
CY2013Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
49521000
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2082000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
3697000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3860000
CY2013Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
102300000
CY2013Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
98439000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2261996000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21634000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-30713000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13605000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5706000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
258646000
CY2013Q4 us-gaap Liabilities
Liabilities
289359000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12193000
CY2013Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
342000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70790000
CY2013Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
67700000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
176557000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5485000
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
2296402000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
287617000
CY2013Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
298000
CY2013Q4 us-gaap Assets
Assets
258646000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5516000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
76275000
CY2013Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2013Q4 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
1311000
CY2013Q4 mnkd Estimated Amounts Credit Exchange Receivable Current
EstimatedAmountsCreditExchangeReceivableCurrent
0
CY2013Q4 mnkd Estimated Amounts Credit Exchange Receivable Noncurrent
EstimatedAmountsCreditExchangeReceivableNoncurrent
298000
CY2014Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
1400000
CY2014Q3 mnkd Long Term Purchase Commitment Expiration Date
LongTermPurchaseCommitmentExpirationDate
2019-12-31
CY2014Q3 mnkd Longterm Purchase Commitment Renewal Time Period
LongtermPurchaseCommitmentRenewalTimePeriod
P2Y
CY2014Q3 mnkd Total Consideration Received
TotalConsiderationReceived
9300000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
35900000
mnkd Number Of Employees With Modified Equity Based Compensation Awards
NumberOfEmployeesWithModifiedEquityBasedCompensationAwards
124 Employee
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-94681000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2095000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
5523000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31304000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8820000
us-gaap Operating Expenses
OperatingExpenses
122784000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42053000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1929000
us-gaap Share Based Compensation
ShareBasedCompensation
31304000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
242000
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-686000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
51658000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
286889000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
133944425 shares
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
708000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-137907000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
us-gaap Operating Income Loss
OperatingIncomeLoss
-122784000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-137910000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
598000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1821000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-137907000
us-gaap Net Income Loss
NetIncomeLoss
-137907000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4000
us-gaap Interest Paid
InterestPaid
7862000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
79500000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
5123000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
637000
us-gaap Interest Expense Debt
InterestExpenseDebt
10052000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
31963000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3525000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10109000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
128465000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1821000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
80731000
dei Entity Registrant Name
EntityRegistrantName
MANNKIND CORP
dei Trading Symbol
TradingSymbol
MNKD
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Type
DocumentType
10-Q
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
39830000
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.85 pure
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
381332000 shares
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Entity Central Index Key
EntityCentralIndexKey
0000899460
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
47820744 shares
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14768000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
130000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-161941000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
us-gaap Operating Income Loss
OperatingIncomeLoss
-149524000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-161948000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
93500000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1638000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-7000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19134000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
7000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-161941000
us-gaap Net Income Loss
NetIncomeLoss
-161941000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4000
us-gaap Interest Paid
InterestPaid
9740000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
26844000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
3809000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
46755000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7386000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
150000000
us-gaap Operating Expenses
OperatingExpenses
149524000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
40000000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
2164000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
681000
us-gaap Interest Expense Debt
InterestExpenseDebt
11895000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
101675000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3003000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
15574000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
71729000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9884000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
82684000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
66840000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13692000
us-gaap Share Based Compensation
ShareBasedCompensation
46755000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2186000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
20000000
mnkd Non Cash Financing Activities Loan Commitment Asset
NonCashFinancingActivitiesLoanCommitmentAsset
1753000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1237000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
70000000
mnkd Amortization Period Of Lease Hold Improvements
AmortizationPeriodOfLeaseHoldImprovements
P4Y
mnkd Nominal Lending Fee
NominalLendingFee
0.01
mnkd Percentage Of Credit Exchange Receivable
PercentageOfCreditExchangeReceivable
0.65 pure
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-765000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
38573000
mnkd Write Off Of Derivative Liability
WriteOffOfDerivativeLiability
363000
mnkd Reclassification Of Share Based Awards To Liability
ReclassificationOfShareBasedAwardsToLiability
22963000
mnkd Interest Expense Related To Milestone Payment
InterestExpenseRelatedToMilestonePayment
1850000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1700000000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1685163000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
796779000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-990000
us-gaap Sales Revenue Net
SalesRevenueNet
3166000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18303000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
360000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2458725000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3331000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
us-gaap Operating Income Loss
OperatingIncomeLoss
-2380190000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2458354000
us-gaap Income Taxes Paid
IncomeTaxesPaid
26000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
100000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1028000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
598000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1264000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-11000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1667000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
115000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
354867000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1094000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2481555000
us-gaap Net Income Loss
NetIncomeLoss
-2458343000
us-gaap Investment Income Interest
InvestmentIncomeInterest
37008000
us-gaap Interest Paid
InterestPaid
82344000
us-gaap Stock Issued1
StockIssued1
2758000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
44672000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
22105000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
3089000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
150000000
us-gaap Operating Expenses
OperatingExpenses
2383356000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
159500000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
47298000
us-gaap Interest Expense Debt
InterestExpenseDebt
66981000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
172465000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
35721000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-382000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3460000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1742000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
952000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
156408000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2203177000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3900000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
454000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
19726000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
5248000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
151428000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
6494000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-345549000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
15000000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
387750000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1659976000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
207050000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
552226000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
17039000
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
22260000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
4220000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
796393000
us-gaap Share Based Compensation
ShareBasedCompensation
229859000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2775000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
48000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
20000000
mnkd Collection Of Convertible Preferred Stock Subscriptions Receivable
CollectionOfConvertiblePreferredStockSubscriptionsReceivable
50000000
mnkd Accrued Interest On Investments Net Of Amortization Of Discounts
AccruedInterestOnInvestmentsNetOfAmortizationOfDiscounts
191000
mnkd Issuance Of Redeemable Convertible Preferred Stock
IssuanceOfRedeemableConvertiblePreferredStock
4296000
mnkd Put Shares Sold To Majority Stockholder
PutSharesSoldToMajorityStockholder
623000
mnkd Non Cash Financing Activities Loan Commitment Asset
NonCashFinancingActivitiesLoanCommitmentAsset
1753000
mnkd Issuance Of Convertible Preferred Stock Subscriptions
IssuanceOfConvertiblePreferredStockSubscriptions
50000000
mnkd Forward Purchase Contract Contribution To Additional Paid In Capital
ForwardPurchaseContractContributionToAdditionalPaidInCapital
29317000
mnkd Issuance Of Put Option By Stockholder
IssuanceOfPutOptionByStockholder
2949000
mnkd Put Option Redemption By Stockholder
PutOptionRedemptionByStockholder
1921000
mnkd Reclassification Of Forward Purchase Contract To Additional Paid In Capital
ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital
28080000
mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
290334000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-1062000
mnkd Stock Expense For Shares Issued Pursuant To Research Agreement
StockExpenseForSharesIssuedPursuantToResearchAgreement
3018000
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-25070000
mnkd Increase In Additional Paid In Capital Resulting From Merger
IncreaseInAdditionalPaidInCapitalResultingFromMerger
171154000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
1582897000
mnkd Write Off Of Derivative Liability
WriteOffOfDerivativeLiability
363000
mnkd Reclassification Of Share Based Awards To Liability
ReclassificationOfShareBasedAwardsToLiability
22963000
mnkd Interest Expense Related To Milestone Payment
InterestExpenseRelatedToMilestonePayment
1850000
CY2014Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
17700 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
46400 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
296386000 shares
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50818000
CY2013Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-44762000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36520000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50819000
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000
CY2013Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1000
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50818000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-50818000
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15943000
CY2013Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2874000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
44762000
CY2013Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1745000
CY2013Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
216000
CY2013Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
4323000
CY2013Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
27281000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17481000
CY2014Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
252600 shares
CY2014Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
158600 shares
CY2014Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
1053900 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
394163000 shares
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2014Q3 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
720000 shares
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7000
CY2014Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-38266000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36527000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7898000
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-7000
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36520000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-36520000
CY2014Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-4827000
CY2014Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2414000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
38266000
CY2014Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
729000
CY2014Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
231000
CY2014Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
5424000
CY2014Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
19178000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19088000
CY2014Q3 mnkd Allocated Share Based Compensation Expense Credit
AllocatedShareBasedCompensationExpenseCredit
12900000

Files In Submission

Name View Source Status
0001193125-14-406347-index-headers.html Edgar Link pending
0001193125-14-406347-index.html Edgar Link pending
0001193125-14-406347.txt Edgar Link pending
0001193125-14-406347-xbrl.zip Edgar Link pending
d783199d10q.htm Edgar Link pending
d783199dex101.htm Edgar Link pending
d783199dex102.htm Edgar Link pending
d783199dex103.htm Edgar Link pending
d783199dex311.htm Edgar Link pending
d783199dex312.htm Edgar Link pending
d783199dex32.htm Edgar Link pending
d783199dex414.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g783199g44l91.jpg Edgar Link pending
mnkd-20140930.xml Edgar Link completed
mnkd-20140930.xsd Edgar Link pending
mnkd-20140930_cal.xml Edgar Link unprocessable
mnkd-20140930_def.xml Edgar Link unprocessable
mnkd-20140930_lab.xml Edgar Link unprocessable
mnkd-20140930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending